Our science & medical news
RSS feedEndothelin: a new player in muscle fibrosis – Interview with Capucine Trollet
Mona Bensalah completed her thesis under the supervision of Elisa Negroni and Vincent Mouly in the team “Cellular and molecular orchestration in muscle regeneration, during aging and in pathologies” directed by Capucine Trollet and Vincent Mouly, at the Institute’s Myology Research Centre. Her work, completed by that of Laura Muraine, has just been published in … [Read more]
ERN EURO-NMD webinar, May 12th: Pr Michelangelo Mancuso (Italy)
Primary Mitochondrial Myopathies Thursday May 12th, 2022 – 16:00-17:00 (Paris time) Prof. Michelangelo Mancuso (Neurologist at the Neurological Clinic of Cisanello Hospital and Associate Professor of Neurology at the University of Pisa, Italy) Webinar organised by EURO-NMD in collaboration with ERN-RND and EAN.
3-year study of lower limb muscles in patients with dysferlinopathy using MRI and 31P NMR spectroscopy
Studies of the natural history of neuromuscular diseases are essential to understand the evolution of the diseases and to find relevant evaluation criteria. Dysferlinopathy is a neuromuscular disease characterized by an active inflammatory and degenerative process ultimately leading to muscle fiber necrosis and replacement of muscle by fibrous and fatty tissue. An international team involving … [Read more]
Myology 2022 and mitoNice 2022: programs are online!
You can now find the program of the two major scientific congresses organized by the AFM-Téléthon next September in Nice on the dedicated site: Myology 2022, which will be held from September 12 to 15, will bring together more than 900 international experts in muscle and its diseases while mitoNice 2022 gives mitochondria specialists an … [Read more]
My thesis in 180 seconds: Louison Lallemant, 2022 Public prize winner – Interview
Louison Lallemant is a doctoral student in the group of Mario Gomes-Pereira and Geneviève Gourdon within the REDs team led by Denis Furling and Geneviève Gourdon, at the Institute’s Myology Centre for Research. She has just won the Public Prize awarded by Internet users and the public attending the Sorbonne University Final of the “My … [Read more]
Myasthenia gravis: launch of the MYaEX study
The Institute of Myology and AFM-Telethon have launched MYaEX, a large national survey regarding persons with myasthenia gravis, congenital myasthenic syndrome or Lambert Eaton myasthenic syndrome. The main objective of this study is to help to understand what determines the practice of physical exercise in these pathologies of the neuromuscular junction, and to identify the factors … [Read more]
ERN EURO-NMD webinar, Feb 24th: Pr Rita Horvath (UK)
Targeted Therapies for Leigh Syndrome: Systematic Review and Steps Towards a “Treatabolome” Thursday February 24th, 2022 – 16:00-17:00 (Paris time) Prof Rita Horvath (University of Cambridge, Cambridge Rare Diseases Centre, UK) “Mitochondrial Disorders Thematic Month” Webinar organised by EURO-NMD.
A new approach to gene therapy for Steinert disease – Interview with Denis Furling
The Denis Furling* team (Paris, France), in collaboration with the Nicolas Sergeant** team (Lille, France), has developed and tested a new approach to gene therapy, a so-called “decoy” approach, for Steinert disease or myotonic dystrophy type 1 (DM1). The strategy is based on the expression of modified proteins that will bind to the pathological expansions … [Read more]
ERN EURO-NMD webinar, Feb 17th: Pr Michelangelo Mancuso (Italy)
Primary mitochondrial myopathies Thursday February 17th, 2022 – 16:00-17:00 (Paris time) Prof Michelangelo Mancuso (University of Pisa & AOUP, Italy) “Mitochondrial Disorders Thematic Month” Webinar organised by EURO-NMD
Back to the 26th Journées of the Francophone Society of the Peripheral Nerve
The 26th “Journées of the Francophone Society of the Peripheral Nerve” took place on January 21 & 22, 2022 at the New Cap Event Center in Paris. They brought together 240 participants, health professionals, clinicians, researchers on cross-cutting themes from nerve to muscle. New therapeutic targets in neuromuscular diseases, and in particular in autoimmune myasthenia … [Read more]
